These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 26997435)

  • 1. Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness.
    Tsujikawa H; Masugi Y; Yamazaki K; Itano O; Kitagawa Y; Sakamoto M
    Hum Pathol; 2016 Apr; 50():24-33. PubMed ID: 26997435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of AT-rich interactive domain 1A in hepatocellular carcinoma.
    Abe H; Hayashi A; Kunita A; Sakamoto Y; Hasegawa K; Shibahara J; Kokudo N; Fukayama M
    Int J Clin Exp Pathol; 2015; 8(3):2763-70. PubMed ID: 26045782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma.
    Liu XH; Pan MH; Lu ZF; Wu B; Rao Q; Zhou ZY; Zhou XJ
    Dig Liver Dis; 2008 Jul; 40(7):560-7. PubMed ID: 18294932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
    Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
    Hou KZ; Fu ZQ; Gong H
    World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].
    Pozharisskiĭ KM; Granov DA; Ten VP; Kubaĭbergenova AG; Leenman EE; Rasskazov AI
    Vopr Onkol; 2008; 54(4):417-33. PubMed ID: 18942395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
    Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
    J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
    Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
    Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma.
    Zhang D; Ma X; Sun W; Cui P; Lu Z
    Int J Clin Exp Pathol; 2015; 8(3):3386-94. PubMed ID: 26045876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.
    Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A
    J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of biliary antigen and its clinical significance in hepatocellular carcinoma.
    Yoon DS; Jeong J; Park YN; Kim KS; Kwon SW; Chi HS; Park C; Kim BR
    Yonsei Med J; 1999 Oct; 40(5):472-7. PubMed ID: 10565259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steatotic and nonsteatotic scirrhous hepatocellular carcinomas reveal distinct clinicopathological features.
    Hatano M; Ojima H; Masugi Y; Tsujikawa H; Hiraoka N; Kanai Y; Shimada K; Shinoda M; Sakamoto M
    Hum Pathol; 2019 Apr; 86():222-232. PubMed ID: 30597153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.
    Kim H; Park YN
    Dig Dis; 2014; 32(6):778-85. PubMed ID: 25376296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
    Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
    Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Yamashita T; Budhu A; Forgues M; Wang XW
    Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of proteins associated with hypoxia and Wnt pathway activation is of prognostic significance in hepatocellular carcinoma.
    Srivastava S; Thakkar B; Yeoh KG; Ho KY; Teh M; Soong R; Salto-Tellez M
    Virchows Arch; 2015 May; 466(5):541-8. PubMed ID: 25742908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
    Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling.
    Liu Y; Zhou R; Yuan X; Han N; Zhou S; Xu H; Guo M; Yu S; Zhang C; Yin T; Wu K
    Oncotarget; 2015 Apr; 6(11):8621-34. PubMed ID: 25940701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.